Reversal of neuromuscular blockade by sugammadex after continuous infusion of rocuronium in patients randomized to sevoflurane or propofol maintenance anesthesia

Anesthesiology

Volumn 111, Issue 1, 2009, Pages 30-35

  Rex, Christopher ^a   Wagner, Stefanie ^b   Spies, Claudia ^c   Scholz, Jens ^d   Rietbergen, Henk ^e   Heeringa, Marten ^e   Wulf, Hinnerk ^b  

^a Klinikum am Steinenberg   (Germany)

^b UNIVERSITY HOSPITAL MARBURG   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY OF KIEL   (Germany)

^e MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROPOFOL; ROCURONIUM; SEVOFLURANE; SUGAMMADEX;

ADULT; ANESTHESIA INDUCTION; ANESTHETIC RECOVERY; ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; FEMALE; GENERAL ANESTHESIA; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NERVE STIMULATION; NEUROMUSCULAR BLOCKADE REVERSAL; NEUROMUSCULAR BLOCKING; PATIENT SELECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; STATISTICAL ANALYSIS;

EID: 67650085874     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3181a51cb0     Document Type: Article

References (20)

1. Booij L, de Boer HD, Van Egmond J: Reversal agents for nondepolarizing neuromuscular blockade: Reasons for and development of a new concept. Semin Anesth Periop Med Pain 2002; 21:92-8
2. Bom A, Bradley M, Cameron K, Clark JK, Van Egmond J, Feilden H, MacLean EJ, Muir AW, Palin R, Rees DC, Zhang MQ: A novel concept of reversing neuromuscular block: Chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host. Angew Chem Int Ed Engl 2002; 41:266-70
3. Suy K, Morias K, Cammu G, Hans P, van Duijnhoven WG, Heeringa M,Demeyer I: Effective reversal of moderate rocuronium- or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent. ANESTHESIOLOGY 2007; 106:283-8
4. Sparr HJ, Vermeyen KM, Beaufort AM, Rietbergen H, Proost JH, Saldien V,Velik-Salchner C, Wierda JM: Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study:Efficacy, safety, and pharmacokinetics. ANESTHESIOLOGY 2007; 106:935-43
5. McCoy EP, Mirakhur RK, Maddineni VR, Loan PB, Connolly F: Administration of rocuronium (Org 9426) by continuous infusion and its reversibility with anticholinesterases. Anaesthesia 1994; 49:940-5
6. Jellish WS, Brody M, Sawicki K, Slogoff S: Recovery from neuromuscular blockade after either bolus and prolonged infusions of cisatracurium or rocuro- nium using either isoflurane or propofol-based anesthetics. Anesth Analg 2000; 91:1250-5
7. Wulf H, Ledowski T, Linstedt U, Proppe D, Sitzlack D: Neuromuscular blocking effects of rocuronium during desflurane, isoflurane, and sevoflurane and anaesthesia. Can J Anaesth 1998; 45:526-32
8. Reid JE, Breslin DS, Mirakhur RK, Hayes AH: Neostigmine antagonism of rocuronium block during anesthesia with sevoflurane, isoflurane or propofol.Can J Anaesth 2001; 48:351-5
9. Vanacker BF, Vermeyen KM, Struys MM, Rietbergen H, Vandermeersch E, Saldien V, Kalmar AF, Prins ME: Reversal of rocuronium-induced neuromuscular block with the novel drug sugammadex is equally effective under maintenance anesthesia with propofol or sevoflurane. Anesth Analg 2007; 104:563-8
10. Viby-Mogensen J: Dose-response relationship and time course of action of rocuronium bromide in perspective. Eur J Anaesthesiol 1994; 9(Suppl):28-32
11. Epemoluo, Bom A, Hope F, MasonR: Reversalofneuromuscularblockade and simultaneous increase in plasma rocuronium concentration after the intravenous infusion of the novel reversal agent Org 25969. ANESTHESIOLOGY 2003;99:632-7
12. Hollander M, Wolfe DA: Nonparametric Statistical Methods. New York, John Wiley & Sons, Inc., 1973, pp 75-9
13. de Boer HD, van Egmond J, van de Pol F, Bom A, Booij LHDJ: Chemical encapsulation of rocuronium by synthetic cyclodextrin derivatives: Reversal of neuromuscular block in anaesthetized Rhesus monkeys. Br J Anaesth 2006;96:201-6
14. de Boer HD, van Egmond J, van de Pol F, Bom A, Booij LH: Sugammadex, a new reversal agent for neuromuscular block induced by rocuronium in the anaesthetized Rhesus monkey. Br J Anaesth 2006; 96:473-9
15. Groudine SB, Soto R, Lien C, Drover D, Roberts K: A randomized, dose-finding, phase II study of the selective relaxant binding drug, sugammadex, capable of safely reversing profound rocuronium-induced neuromuscular block.Anesth Analg 2007; 104:555-62
16. Shields M, Giovanelli M, Mirakhur RK, Moppett I, Adams J, Hermens Y:org 25969 (sugammadex), a selective relaxant binding agent for antagonism of prolonged rocuronium-induced neuromuscular block. Br J Anaesth 2006; 96:36-43
17. Shanks CA, Fragen RJ, Ling D: Continuous intravenous infusion of rocu-ronium (ORG 9426) in patients receiving balanced, enflurane, or isoflurane anesthesia. ANESTHESIOLOGY 1993; 78:649-51
18. Woloszczuk-Gebicka B, Lapczynski T, Wierzejski W: The influence of halothane, isoflurane and sevoflurane on rocuronium infusion in children. Acta Anaesthesiol Scand 2001; 45:73-7
19. Sparr HJ, Khuenl-Brady KS, Eriksson LI: Pharmacodynamics and pharma- cokinetics of rocuronium following continuous infusion in patients during intravenous anaesthesia. Eur J Anaesthesiol 1994; 9(Suppl):63-5
20. McCoy EP, Mirakhur RK, Maddineni VR, Wierda JMKH, Proost JH: Phar-macokinetics of rocuronium after bolus and continuous infusion during halo-thane anaesthesia. Br J Anaesth 1996; 76:29-33